Clinical Trials List
2023-11-01 - 2027-12-31
Phase II
Recruiting5
ICD-10C25.0
Malignant neoplasm of head of pancreas
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9157.0
Malignant neoplasm of head of pancreas
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳珈妤 無
- Chang-Fang Chiu 無
- Chi-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Ping Hung 無
- Pei-Chang Lee 無
- 李癸川 無
- Ming-Huang Chen 無
- Shao-Jung Hsu 無
- 姜乃榕 無
- Hung-Yuan Yu 無
- 許紹榮 無
- 李癸川 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 余紹銘 無
- Jen-Shi Chen 無
- 徐執中 無
- Po-Jung Su 無
- Hung-Chih Hsu 無
- Wen-Chi Shen 無
- 陳建銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Jui Yen 無
- Chien-Jui Huang 無
- 蘇勇曄 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
180 participants
